Pneumocandin antifungal lipopeptides. The phenolic hydroxyl is required for 1,3-β-glucan synthesis inhibition.
- 31 October 1993
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 3 (10), 2039-2042
- https://doi.org/10.1016/s0960-894x(01)81010-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Reduction studies of antifungal echinocandin lipopeptides. One step conversion of echinocandin B to echinocandin C.Tetrahedron Letters, 1992
- Systemically Administered Antifungal AgentsDrugs, 1992
- Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species.The Journal of Antibiotics, 1992
- Pneumocandins from Zalerion arboricola. III. Structure elucidation.The Journal of Antibiotics, 1992
- Pneumocandins from Zalerion arboricola. I. Discovery and isolation.The Journal of Antibiotics, 1992
- Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP)Journal of Medicinal Chemistry, 1992
- Biosynthesis of ?-glucans in fungiAntonie van Leeuwenhoek, 1991
- Effect of Aculeacin A, a Wall-Active Antibiotic, on Synthesis of the Yeast Cell WallMicrobiology and Immunology, 1985
- Recent studies on veratrum alkaloids: a new reaction of sodium triacetoxyborohydride [NaBH(OAc)3]Tetrahedron Letters, 1983
- On the mode of action of a new antifungal antibiotic, aculeacin A: Inhibition of cell wall synthesis in Saccharomyces cerevisiae.The Journal of Antibiotics, 1977